Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. (Q48459917)

11 February 2018

title

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. (English)

1 reference

11 February 2018

main subject

schizophrenia

0 references

author

Cynthia Shannon Weickert

5

object named as

Weickert CS

1 reference

11 February 2018

author name string

Webster MJ

1

1 reference

11 February 2018

Knable MB

2

1 reference

11 February 2018

O'Grady J

3

1 reference

11 February 2018

Orthmann J

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

11 February 2018

published in

Molecular Psychiatry

1 reference

11 February 2018

volume

7

1 reference

11 February 2018

page(s)

985-94, 924

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001139

exact match

0 references

cites work

Regulation of gene expression by corticoid hormones in the brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Long-lasting reduction of glucocorticoid receptor immunoreactivity in the hippocampal field CA1 but not in the dentate gyrus after neonatal treatment with corticosterone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Primary structure and expression of a functional human glucocorticoid receptor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Tissue localization of 11 beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

In situ hybridization mapping of glucocorticoid receptor messenger ribonucleic acid in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoid receptor gene expression in the embryonic rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal atrophy in recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal pathologic findings in schizophrenia. A morphometric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal neuron number in schizophrenia. A stereological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Controversies surrounding glucocorticoid-mediated cell death in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Stress and hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Counting individual sulfur atoms in a protein by ultrahigh-resolution Fourier transform ion cyclotron resonance mass spectrometry: experimental resolution of isotopic fine structure in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Prefrontal gray matter volume reduction in first episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

The human entorhinal cortex: a cytoarchitectonic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Temporolimbic volume reductions in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Stress and schizophrenia: the importance of cognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001139

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001139

1 reference

11 February 2018

PubMed ID

12399952

1 reference

11 February 2018